DSpace Repository

Binding energy analysis for wild-type and Y181C mutant HIV-1 RT/8-Cl TIBO complex structures: Quantum chemical calculations based on the ONIOM method

Show simple item record

dc.contributor.author Saen-Oon S.
dc.contributor.author Kuno H.
dc.contributor.author Hannongbua S.
dc.date.accessioned 2021-04-05T04:32:29Z
dc.date.available 2021-04-05T04:32:29Z
dc.date.issued 2005
dc.identifier.issn 8873585
dc.identifier.other 2-s2.0-28644442414
dc.identifier.uri https://ir.swu.ac.th/jspui/handle/123456789/15072
dc.identifier.uri https://www.scopus.com/inward/record.uri?eid=2-s2.0-28644442414&doi=10.1002%2fprot.20690&partnerID=40&md5=bdfa20e816813bf3ae48971687134dd4
dc.description.abstract Two-layered and three-layered ONIOM calculations were performed to compare the binding energies of 8-Cl TIBO inhibitor when bound into the human immunodeficiency virus reverse transcriptase binding pocket and a Y181C variant. Both consisted of 20 residues within a radius of 15 Å. A combination of different methods [HP2/6-31G(d), B3LYP/6-31G(d,p), and PM3] were performed to take advantage of ONIOM's layering strategy analysis. The obtained results clearly indicate that the Y181C mutation reduces the binding affinity and stability of the inhibitor by approximately 8-9 kcal/mol as obtained from different combined MO:MO methods. Analyses regarding the energetic components of the interaction and deformation energies for 8-Cl TIBO inhibitor upon binding were also examined extensively. Additional calculations involving the interaction energies between 8-Cl TIBO with individual residues surrounding the binding pocket were performed at MP2/6-31G(d,p) and B3LYP/6-31G(d,p) levels of theory to gain more insight into the energetic differences of wild-type and Y181C mutant type at the atomistic level. © 2005 Wiley-Liss, Inc.
dc.subject 4,5,6,7 tetrahydroimidazo 8 chloro 5 methyl (3 methyl 2 butenyl)imidazo
dc.subject RNA directed DNA polymerase
dc.subject RNA directed DNA polymerase inhibitor
dc.subject unclassified drug
dc.subject analytic method
dc.subject article
dc.subject binding affinity
dc.subject calculation
dc.subject comparative study
dc.subject complex formation
dc.subject drug binding site
dc.subject drug protein binding
dc.subject energy
dc.subject Human immunodeficiency virus 1
dc.subject molecular stability
dc.subject mutation
dc.subject nonhuman
dc.subject priority journal
dc.subject quantum chemistry
dc.subject wild type
dc.subject Amino Acid Substitution
dc.subject Dimerization
dc.subject HIV-1
dc.subject Kinetics
dc.subject Models, Molecular
dc.subject Polymorphism, Single Nucleotide
dc.subject Protein Structure, Secondary
dc.subject Protein Subunits
dc.subject Quantum Theory
dc.subject Recombinant Proteins
dc.subject Reverse Transcriptase Inhibitors
dc.subject RNA-Directed DNA Polymerase
dc.subject Thermodynamics
dc.subject Human immunodeficiency virus
dc.subject Human immunodeficiency virus 1
dc.title Binding energy analysis for wild-type and Y181C mutant HIV-1 RT/8-Cl TIBO complex structures: Quantum chemical calculations based on the ONIOM method
dc.type Article
dc.rights.holder Scopus
dc.identifier.bibliograpycitation Proteins: Structure, Function and Genetics. Vol 61, No.4 (2005), p.859-869
dc.identifier.doi 10.1002/prot.20690


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics